V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003817 | 280002823 | 1.68 | 52 | Neo-adjuvant (N) | 2016-01-18 | 2016-02-02 | DOXORUBICIN + IFOSFAMIDE | N | N | 280026205 | DOXORUBICIN + IFOSFAMIDE |
| 280003818 | 280002823 | 1.65 | 66.1 | Palliative (P) | 2017-12-02 | 2017-12-19 | DOXORUBICIN + IFOSFAMIDE | N | N | 280026205 | DOXORUBICIN + IFOSFAMIDE |
| 280003819 | 280002823 | null | null | Neo-adjuvant (N) | 2016-06-28 | 2016-07-17 | CISPLATIN + FLUOROURACIL | N | N | 280026205 | CISPLATIN + FLUOROURACIL |
| 280003820 | 280002823 | 1.74 | 0 | Curative (C) | 2014-09-16 | 2014-09-30 | CETUXIMAB + RT | N | N | 280026205 | CETUXIMAB + RT |
| 280003821 | 280002823 | 1.56 | null | Neo-adjuvant (N) | 2017-03-22 | 2017-04-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026205 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003822 | 280002824 | 1.64 | 78.2 | null | 2013-03-04 | 2013-03-14 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026220 | CISPLATIN + FLUOROURACIL |
| 280003823 | 280002824 | 1.67 | 66.3 | Palliative (P) | 2018-02-13 | 2018-02-13 | Doxorubicin + Ifosfamide | 02 | N | 280026220 | DOXORUBICIN + IFOSFAMIDE |
| 280003824 | 280002825 | 1.67 | 53.5 | Neo-adjuvant (N) | null | 2013-10-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280026223 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003825 | 280007380 | 1.74 | null | Curative (C) | 2016-11-10 | 2016-11-10 | Cetuximab + Radiotherapy Load | null | null | 280026224 | CETUXIMAB + RT |
| 280003826 | 280002826 | 1.73 | 74 | null | 2015-12-30 | 2016-01-13 | CETUXIMAB + RT | 02 | Y | 280026225 | CETUXIMAB + RT |
| 280003827 | 280002826 | 1.79 | null | Curative (C) | 2017-11-02 | 2017-11-02 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280026225 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003828 | 280002827 | 1.63 | 114 | Neo-adjuvant (N) | 2015-01-16 | 2015-01-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026231 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003829 | 280002827 | 1.78 | 84 | Palliative (P) | 2013-10-12 | 2013-10-12 | Doxorubicin + Ifosfamide | 02 | N | 280026231 | DOXORUBICIN + IFOSFAMIDE |
| 280003830 | 280002828 | 1.7 | 62 | null | 2014-07-04 | 2014-07-22 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 280026235 | CISPLATIN + FLUOROURACIL |
| 280003831 | 280007383 | 1.77 | 71 | Neo-adjuvant (N) | null | 2017-11-22 | Cetuximab + Radiotherapy Load | N | N | 280026236 | CETUXIMAB + RT |
| 280003832 | 280002829 | 1.68 | 74.6 | Curative (C) | 2016-11-18 | 2016-11-19 | Cetuximab + Radiotherapy Load | N | Y | 280026240 | CETUXIMAB + RT |
| 280003833 | 280002829 | null | 93 | Neo-adjuvant (N) | 2015-11-28 | 2015-12-12 | Doxorubicin + Ifosfamide | 02 | N | 280026240 | DOXORUBICIN + IFOSFAMIDE |
| 280003834 | 280002829 | 1.8 | 93 | Palliative (P) | 2014-10-07 | 2014-10-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026240 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003835 | 280002829 | 1.66 | 63.75 | Palliative (P) | 2014-05-05 | 2014-05-05 | Doxorubicin + Ifosfamide | 2 | N | 280026240 | DOXORUBICIN + IFOSFAMIDE |
| 280003836 | 280002830 | 1.67 | 74.6 | Neo-adjuvant (N) | 2016-12-27 | 2016-12-27 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280026247 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003837 | 280002831 | 1.75 | 88.3 | Neo-adjuvant (N) | 2014-07-15 | 2014-08-02 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280026248 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003838 | 280002831 | 1.82 | 71.1 | null | 2015-08-27 | 2015-09-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026248 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003839 | 280002832 | 1.5 | 111.5 | Curative (C) | 2015-09-07 | 2015-09-07 | CETUXIMAB + RT | 2 | N | 280026250 | CETUXIMAB + RT |
| 280003840 | 280002833 | 1.88 | 81 | null | 2015-10-02 | 2015-10-03 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026255 | CISPLATIN + FLUOROURACIL |
| 280003841 | 280007386 | 1.7 | 84 | Neo-adjuvant (N) | 2014-03-13 | 2014-03-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280026256 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003842 | 280002834 | 1.55 | 64 | Curative (C) | 2014-07-18 | 2014-07-24 | Doxorubicin + Ifosfamide | N | N | 280026258 | DOXORUBICIN + IFOSFAMIDE |
| 280003843 | 280002835 | null | 62.6 | Curative (C) | 2014-11-30 | 2014-12-12 | Cisplatin + Docetaxel +Fluorouracil | N | null | 280026259 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003844 | 280002835 | null | null | Curative (C) | null | 2017-04-25 | Cisplatin +Fluorouracil (3 wk) | null | null | 280026259 | CISPLATIN + FLUOROURACIL |
| 280003845 | 280002836 | null | 81.4 | Curative (C) | null | 2017-04-01 | CETUXIMAB + RT | null | null | 280026264 | CETUXIMAB + RT |
| 280003846 | 280007388 | null | 95.5 | Neo-adjuvant (N) | null | 2014-10-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280026265 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003847 | 280002837 | null | null | Palliative (P) | 2015-06-15 | 2015-06-20 | Doxorubicin + Ifosfamide | N | N | 280026266 | DOXORUBICIN + IFOSFAMIDE |
| 280003848 | 280002837 | 1.61 | 78.9 | Not known (9) | 2015-05-02 | 2015-05-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280026266 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003849 | 280002838 | 1.73 | 82 | Neo-adjuvant (N) | 2014-12-17 | 2014-12-22 | DOXORUBICIN + IFOSFAMIDE | N | N | 280026268 | DOXORUBICIN + IFOSFAMIDE |
| 280003850 | 280007390 | 1.75 | 72.9 | Curative (C) | 2014-04-23 | 2014-05-08 | Cetuximab + Radiotherapy Load | N | Y | 280026269 | CETUXIMAB + RT |
| 280003851 | 280007390 | 1.74 | 71.2 | Neo-adjuvant (N) | 2015-01-07 | 2015-01-07 | CISPLATIN + FLUOROURACIL | 02 | N | 280026269 | CISPLATIN + FLUOROURACIL |
| 280003852 | 280002839 | null | null | null | 2013-05-24 | 2013-06-14 | Cetuximab + Radiotherapy Load | 02 | N | 280026272 | CETUXIMAB + RT |
| 280003853 | 280002839 | null | 95 | Neo-adjuvant (N) | 2013-08-25 | 2013-08-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026272 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003854 | 280002840 | null | null | null | 2013-12-23 | 2014-01-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280026275 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003855 | 280007392 | 1.65 | 75.1 | null | 2017-01-13 | 2017-01-14 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280026277 | CISPLATIN + FLUOROURACIL |
| 280003856 | 280002841 | 1.58 | 81.2 | Not known (9) | 2013-06-29 | 2013-07-21 | CISPLATIN + FLUOROURACIL | N | N | 280026279 | CISPLATIN + FLUOROURACIL |
| 280003858 | 280007393 | 1.69 | 46 | Neo-adjuvant (N) | 2014-09-12 | 2014-09-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280026282 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003859 | 280007393 | 1.75 | null | Neo-adjuvant (N) | 2017-07-01 | 2017-07-08 | CISPLATIN + FLUOROURACIL | null | null | 280026282 | CISPLATIN + FLUOROURACIL |
| 280003860 | 280002843 | 1.61 | 86.9 | Curative (C) | 2016-01-14 | 2016-01-18 | CETUXIMAB + RT | N | Y | 280026291 | CETUXIMAB + RT |
| 280003861 | 280002844 | 1.73 | 90 | Neo-adjuvant (N) | null | 2017-08-07 | CISPLATIN + FLUOROURACIL | N | N | 280026292 | CISPLATIN + FLUOROURACIL |
| 280003862 | 280002844 | 1.75 | null | Neo-adjuvant (N) | 2014-03-03 | 2014-03-25 | Doxorubicin + Ifosfamide | N | Y | 280026292 | DOXORUBICIN + IFOSFAMIDE |
| 280003863 | 280002845 | 1.57 | 70.2 | Not known (9) | 2015-07-29 | 2015-08-17 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026297 | CISPLATIN + FLUOROURACIL |
| 280003864 | 280002845 | 1.78 | 51.5 | Curative (C) | 2016-07-07 | 2016-08-03 | CETUXIMAB + RT | null | Y | 280026297 | CETUXIMAB + RT |
| 280003865 | 280002846 | 1.74 | 90 | null | 2013-11-04 | 2013-11-07 | CETUXIMAB + RT | N | Y | 280026301 | CETUXIMAB + RT |
| 280003866 | 280002846 | null | null | Palliative (P) | null | 2013-05-21 | Doxorubicin + Ifosfamide | N | N | 280026301 | DOXORUBICIN + IFOSFAMIDE |
| 280003867 | 280002847 | 1.72 | 80.5 | Neo-adjuvant (N) | 2016-09-25 | 2016-09-25 | Doxorubicin + Ifosfamide | 02 | N | 280026305 | DOXORUBICIN + IFOSFAMIDE |